Related Experiment Video
Updated: Apr 26, 2026

08:59
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
2.5K
A cell-based functional assay using a green fluorescent protein-based calcium indicator dCys-GCaMP
Assay and Drug Development Technologies
|August 9, 2014
Summary
A novel calcium (Ca2+) indicator, dCys-GCaMP, enables a rapid cell-based assay for drug discovery. This assay simplifies intracellular Ca2+ level measurement, offering advantages over traditional methods.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Intracellular calcium (Ca2+) level measurement is crucial for drug discovery.
- Existing assays often involve complex dye-loading or substrate-loading steps.
Purpose of the Study:
- To introduce a novel Ca2+ indicator, dCys-GCaMP, derived from green fluorescent protein.
- To develop a rapid, simple, and sensitive cell-based functional assay for measuring intracellular Ca2+ changes.
- To demonstrate the assay's utility in drug discovery, particularly for ionotropic and G protein-coupled receptors.
Main Methods:
- Development of the dCys-GCaMP Ca2+ indicator.
- Establishment of a cell-based functional assay using HEK293 cells coexpressing NMDA receptors and dCys-GCaMP.
- Stimulation with glutamate and assessment of fluorescence changes in response to agonists, antagonists, channel blockers, and modulators.
- Comparison of results with conventional assays (Fluo-4) and literature values.
- Application to the α1A adrenergic receptor (a G protein-coupled receptor).
Main Results:
- The dCys-GCaMP assay demonstrated sensitivity and reliability in measuring cellular responses to NMDA receptor modulators.
- Fluorescence intensity increased in an agonist concentration-dependent manner and was blocked by antagonists and channel blockers.
- Pharmacological parameters obtained using dCys-GCaMP closely matched those from conventional assays and literature.
- The assay proved adaptable for G protein-coupled receptors, exemplified by studies on the α1A adrenergic receptor.
- Initial evaluation suggested suitability for high-throughput screening.
Conclusions:
- The dCys-GCaMP assay provides a sensitive, reliable, and simplified method for measuring intracellular Ca2+ dynamics.
- This novel assay eliminates the need for dye-loading or substrate-loading, streamlining drug discovery processes.
- The assay is versatile, applicable to both ionotropic and G protein-coupled receptors, and adaptable for high-throughput screening environments.
More Related Videos
08:01Author Spotlight: Investigating Viral Disruption of Intestinal Epithelial Signaling – Research Insights and Future Directions
Published on: January 19, 2024
2.0K
05:04In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
Published on: February 22, 2022
2.9K